Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Inorg Chem ; 52(23): 13341-50, 2013 Dec 02.
Article in English | MEDLINE | ID: mdl-24251931

ABSTRACT

This work reports the long sought crystal structures of the title members of the intriguing series of 3d transition metal dichloride monohydrates. The double chain structure which results from rearrangement of the well-known pseudo-octahedral coordination geometry and single chains in the corresponding metal chloride dihydrate is extremely unusual. MnCl2·H2O and CoCl2·H2O each crystallize in orthorhombic space group Pnma with Z = 4 and lattice parameters a = 9.0339(1), 8.8207(3); b = 3.68751(5), 3.5435(1); c = 11.5385(2), 11.2944(4) all in Å and for Mn, Co, respectively. Results are reported also for both fully deuterated systems; the structures remain the same with lattice parameter changes typically much less than 0.1%. Various magnetic properties of MnCl2·D2O and CoCl2·D2O are reported. For the latter, there are no apparent differences, qualitatively or quantitatively, from the previously measured properties of CoCl2·H2O. Interestingly, for the former some differences with respect to MnCl2·H2O are apparent, principally a lower Tmax = 3.10(10) K about which a broad antiferromagnetic maximum is centered, and a larger value χmax = 0.336(3) emu/mol. However, antiferromagnetic ordering appears to occur at essentially the same 2.18(2) K. Results of fits to susceptibilities of MnCl2·D2O and CoCl2·D2O are compared with those obtained before for MnCl2·H2O and CoCl2·H2O. Structural considerations serve to rationalize the physical properties, especially the lower dimensional magnetism of monohydrates.

2.
Br J Ophthalmol ; 89(3): 302-5, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15722309

ABSTRACT

BACKGROUND/AIMS: Conjunctivochalasis, a secondary cause of the watery eye, is frequently seen in the older age group as an elevation of the bulbar conjunctiva lying along the lateral or central lower lid margin. A prospective, interventional, case-controlled clinical and histopathological study was conducted. The relevant features of 18 patients (29 eyes) who had their conjunctivochalasis resected as part of the surgical management of their watery eye syndrome were examined. In the control group, tissue was obtained from an age matched series of 24 normal subjects undergoing routine cataract surgery. METHODS: 24 controls (24 specimens) and 18 patients (29 specimens) had conjunctival strip biopsies, taken from the usual lid margin level bulbar conjunctiva in line with the inferior limbus (controls), and the clinically apparent conjunctivochalasis (patients). These were submitted for histological study. RESULTS: 23 of 24 control sections demonstrated normal conjunctival variation. Four of 29 patient specimens demonstrated a chronic non-granulomatous conjunctivitis, while three eyes of the patient group (two patients) demonstrated features of elastosis. Of the four patients who had the inflammatory infiltrates, three had functional nasolacrimal duct obstructions (FNLDOs) and one had a primary acquired nasolacrimal duct obstruction (PANDO). Of the two patients who had elastosis, one had an FNLDO and the other had normal lacrimal drainage and was Jones 1 positive. CONCLUSION: Six of 18 patients--that is, seven of 29 specimens of conjunctivochalasis demonstrated signs of elastosis or of chronic non-granulomatous inflammation. Clinically, patients had a spectrum of aetiologies of their watery eye syndrome.


Subject(s)
Conjunctiva/pathology , Conjunctival Diseases/pathology , Aged , Aged, 80 and over , Case-Control Studies , Conjunctiva/immunology , Conjunctiva/surgery , Conjunctival Diseases/immunology , Conjunctival Diseases/surgery , Dry Eye Syndromes/pathology , Elasticity , Eyelids/pathology , Eyelids/surgery , Female , Humans , Male , Middle Aged , Prospective Studies
3.
Antimicrob Agents Chemother ; 31(3): 470-2, 1987 Mar.
Article in English | MEDLINE | ID: mdl-2953304

ABSTRACT

In vitro Ro 15-8074 and Ro 19-5247 (T2525), two new oral cephalosporins, were active against 410 penicillin-susceptible and -resistant isolates of Neisseria gonorrhoeae. Two new macrolides, A-56268 and to a lesser extent roxithromycin (RU 28965), were active against Chlamydia trachomatis. A-56268 had activity against N. gonorrhoeae similar to that of erythromycin.


Subject(s)
Anti-Bacterial Agents/pharmacology , Cefmenoxime/analogs & derivatives , Ceftizoxime/analogs & derivatives , Cephalosporins/pharmacology , Chlamydia trachomatis/drug effects , Erythromycin/analogs & derivatives , Leucomycins/pharmacology , Neisseria gonorrhoeae/drug effects , Clarithromycin , Erythromycin/pharmacology , Microbial Sensitivity Tests
4.
Antimicrob Agents Chemother ; 30(4): 590-3, 1986 Oct.
Article in English | MEDLINE | ID: mdl-3098163

ABSTRACT

Management of sexually transmitted diseases is facilitated by having antimicrobial agents with activity against all of the major genital pathogens. Newer quinolones show promise of being active against Neisseria gonorrhoeae and Chlamydia trachomatis. Two quinolones, difloxacin (A-56619) and A-56620, and an oral cephalosporin, cefixime (CL 284,635; FK 027), were evaluated in vitro. All three were highly active against 400 isolates of N. gonorrhoeae, including penicillinase-producing N. gonorrhoeae, N. gonorrhoeae with chromosomally mediated resistance, and isolates with penicillin MICs of less than 1 microgram/ml. Susceptibilities to one antimicrobial agent were usually strongly correlated with susceptibilities to the other antimicrobial agents evaluated, but isolates with increasing resistance to beta-lactams were least likely to show increasing resistance to quinolones. Difloxacin and, to a lesser extent, A-56620 were active against all 10 strains of C. trachomatis, and both had moderate activity against over 200 strains of Gardnerella vaginalis. Based on in vitro activity, difloxacin and A-56620 merit in vivo assessment for management of both C. trachomatis and N. gonorrhoeae infections, and cefixime shows considerable promise for treatment of N. gonorrhoeae infections.


Subject(s)
Anti-Bacterial Agents , Bacteria/drug effects , Cefotaxime/analogs & derivatives , Ciprofloxacin/analogs & derivatives , Fluoroquinolones , Anti-Bacterial Agents/pharmacology , Cefixime , Cefotaxime/pharmacology , Chlamydia trachomatis/drug effects , Ciprofloxacin/pharmacology , Female , Gardnerella vaginalis/drug effects , Genitalia/microbiology , Humans , Male , Microbial Sensitivity Tests , Neisseria gonorrhoeae/drug effects
5.
CMAJ ; 135(5): 489-93, 1986 Sep 01.
Article in English | MEDLINE | ID: mdl-3091234

ABSTRACT

Consecutive isolates of Neisseria gonorrhoeae obtained at a sexually transmitted disease clinic in Vancouver between June 1982 and June 1984 were tested for in-vitro susceptibility to eight antimicrobial agents. Of the 400 isolates 6 (1.5%) were penicillinase-producing N. gonorrhoeae, and for 25 (6.2%) the minimum inhibitory concentrations (MICs) of penicillin were 1.0 to 4.0 micrograms/ml. Ceftriaxone sodium was the most active agent. The MICs were higher than those reported in a Canadian study in 1973-74, except for tetracycline hydrochloride. The patterns of susceptibility of the isolates to one antimicrobial agent correlated significantly with those to each other agent, although the relation was weakest for trimethoprim-sulfamethoxazole and spectinomycin. The results reinforce the need to evaluate local in-vitro susceptibility patterns, especially since the proportion of isolates with relative and absolute resistance to penicillin is increasing.


Subject(s)
Neisseria gonorrhoeae/drug effects , Anti-Bacterial Agents/pharmacology , British Columbia , Ceftriaxone/pharmacology , Drug Combinations/pharmacology , Female , Humans , Male , Microbial Sensitivity Tests , Neisseria gonorrhoeae/isolation & purification , Penicillin Resistance , Penicillinase/metabolism , Penicillins/pharmacology , Sulfamethoxazole/pharmacology , Tetracyclines/pharmacology , Trimethoprim/pharmacology , Trimethoprim, Sulfamethoxazole Drug Combination
SELECTION OF CITATIONS
SEARCH DETAIL
...